Skip to main content

Cutting Edge or Cutting Corners? Innovative Care

  • Chapter
  • First Online:
Dermatoethics

Abstract

Despite an ever-increasing body of scientific evidence, clinical situations often arise for which there are no well-accepted therapies. A physician may respond, for example, by using a drug “off-label” (i.e. to treat a condition for which it is not FDA-approved) or develop a new procedure with the aim of providing more benefit to the patient with less harm than standard approaches permit [1]. An innovative therapy is an unproven treatment approach used in clinical practice for the benefit of a patient. It contrasts with clinical research, which aims at testing the efficacy of an investigational therapy. However, since clinical practice and research often take place in the same facility under the supervision of the same physicians and the use of a novel therapy may both benefit a patient and generate new scientific knowledge, it is not always clear whether a novel therapy is innovative or investigational.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jonsen A, Siegler M, Winslade W. Clinical ethics: a practical approach to ethical decisions in clinical medicine. 6th ed. New York: McGraw-Hill; 2006.

    Google Scholar 

  2. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research(os) 78-0012. DHEW.

    Google Scholar 

  3. Annas GJ. Cancer and the constitution–choice at life’s end. N Engl J Med. 2007;357(4):408–13.

    Article  PubMed  CAS  Google Scholar 

  4. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127(9):2100–3.

    Article  PubMed  CAS  Google Scholar 

  5. Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007;110(1):1–12.

    Article  PubMed  Google Scholar 

  6. NCCN clinical practice guidelines in oncology: merkel cell carcinoma. In: Network NCC, ed. 2010.

    Google Scholar 

  7. Busse PM, Clark JR, Muse VV, Liu V. Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma. N Engl J Med. 2008;358(25):2717–23.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clifford Perlis .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

McGreevy, J., Perlis, C. (2012). Cutting Edge or Cutting Corners? Innovative Care. In: Bercovitch, L., Perlis, C. (eds) Dermatoethics. Springer, London. https://doi.org/10.1007/978-1-4471-2191-6_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2191-6_39

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2190-9

  • Online ISBN: 978-1-4471-2191-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics